Global Benign Prostatic Hyperplasia Treatment Device Sales Market Report 2021

August 2016 | 126 pages | ID: GF2C508B391EN
QYResearch

Abstracts

This report studies sales (consumption) of Benign Prostatic Hyperplasia Treatment Device in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Bard
• Dakang Medical
• Visit Medical
• General Electric Co.
• Siemens AG
• Medtronic Inc.
• Baxter International Inc.
• Covidien plc
• Novartis AG
• Cardinal Health Inc.
• Boston Scientific Corp.
• Toshiba Corp.

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Benign Prostatic Hyperplasia Treatment Device in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Benign Prostatic Hyperplasia Treatment Device in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Benign Prostatic Hyperplasia Treatment Device Sales Market Report 2021

1 BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE OVERVIEW

1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Treatment Device
1.2 Classification of Benign Prostatic Hyperplasia Treatment Device
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Benign Prostatic Hyperplasia Treatment Device
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Benign Prostatic Hyperplasia Treatment Device Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Benign Prostatic Hyperplasia Treatment Device (2011-2021)
  1.5.1 Global Benign Prostatic Hyperplasia Treatment Device Sales, Revenue and Price (2011-2021)
  1.5.2 Global Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
  1.5.3 Global Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)

2 GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Benign Prostatic Hyperplasia Treatment Device Market Competition by Manufacturers
  2.1.1 Global Benign Prostatic Hyperplasia Treatment Device Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Benign Prostatic Hyperplasia Treatment Device Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Benign Prostatic Hyperplasia Treatment Device (Volume and Value) by Type
  2.2.1 Global Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Type (2011-2021)
  2.2.2 Global Benign Prostatic Hyperplasia Treatment Device Revenue and Market Share by Type (2011-2021)
2.3 Global Benign Prostatic Hyperplasia Treatment Device (Volume and Value) by Regions
  2.3.1 Global Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Benign Prostatic Hyperplasia Treatment Device Revenue and Market Share by Regions (2011-2021)
2.4 Global Benign Prostatic Hyperplasia Treatment Device (Volume) by Application

3 NORTH AMERICA BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE (VOLUME, VALUE AND SALES PRICE

3.1 North America Benign Prostatic Hyperplasia Treatment Device Sales and Value (2011-2021)
  3.1.1 North America Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
  3.1.2 North America Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
  3.1.3 North America Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
3.2 North America Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Manufacturers
3.3 North America Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Type
3.4 North America Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Applications

4 CHINA BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE (VOLUME, VALUE AND SALES PRICE

4.1 China Benign Prostatic Hyperplasia Treatment Device Sales and Value (2011-2021)
  4.1.1 China Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
  4.1.2 China Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
  4.1.3 China Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
4.2 China Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Manufacturers
4.3 China Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Type
4.4 China Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Applications

5 EUROPE BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE (VOLUME, VALUE AND SALES PRICE

5.1 Europe Benign Prostatic Hyperplasia Treatment Device Sales and Value (2011-2021)
  5.1.1 Europe Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
  5.1.2 Europe Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
5.2 Europe Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Manufacturers
5.3 Europe Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Type
5.4 Europe Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Applications

6 JAPAN BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE (VOLUME, VALUE AND SALES PRICE

6.1 Japan Benign Prostatic Hyperplasia Treatment Device Sales and Value (2011-2021)
  6.1.1 Japan Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
  6.1.2 Japan Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
6.2 Japan Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Manufacturers
6.3 Japan Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Type
6.4 Japan Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Applications

7 SOUTHEAST ASIA BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales and Value (2011-2021)
  7.1.1 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
7.2 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Manufacturers
7.3 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Type
7.4 Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Applications

8 INDIA BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE (VOLUME, VALUE AND SALES PRICE

8.1 India Benign Prostatic Hyperplasia Treatment Device Sales and Value (2011-2021)
  8.1.1 India Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
  8.1.2 India Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
  8.1.3 India Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
8.2 India Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Manufacturers
8.3 India Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Type
8.4 India Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Applications

9 GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE MANUFACTURERS ANALYSIS

9.1 Bard
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2016)
9.2 Dakang Medical
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Visit Medical
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2016)
9.4 General Electric Co.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Siemens AG
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2016)
9.6 Medtronic Inc.
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2016)
9.7 Baxter International Inc.
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2017)
9.8 Covidien plc
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Novartis AG
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Cardinal Health Inc.
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Benign Prostatic Hyperplasia Treatment Device Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Company One (2015 and 2021)
9.11 Boston Scientific Corp.
9.12 Toshiba Corp.

10 BENIGN PROSTATIC HYPERPLASIA TREATMENT DEVICE TECHNOLOGY AND DEVELOPMENT TREND

10.1 Benign Prostatic Hyperplasia Treatment Device Technology Analysis
10.2 Benign Prostatic Hyperplasia Treatment Device Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Benign Prostatic Hyperplasia Treatment Device
Table Classification of Benign Prostatic Hyperplasia Treatment Device
Figure Global Sales Market Share of Benign Prostatic Hyperplasia Treatment Device by Type in 2015
Table Applications of Benign Prostatic Hyperplasia Treatment Device
Figure Global Sales Market Share of Benign Prostatic Hyperplasia Treatment Device by Applications in 2015
Figure North America Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure China Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure Europe Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure Japan Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure India Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Sales, Revenue and Price (2011-2021)
Figure Global Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
Figure Global Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Sales of Key Manufacturers (2015 and 2016)
Table Global Benign Prostatic Hyperplasia Treatment Device Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Benign Prostatic Hyperplasia Treatment Device Sales Share by Manufacturers
Figure 2016 Benign Prostatic Hyperplasia Treatment Device Sales Share by Manufacturers
Table Global Benign Prostatic Hyperplasia Treatment Device Revenue by Manufacturers (2015 and 2016)
Table Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Manufacturers
Table 2016 Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Manufacturers
Table Global Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Type (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Sales Share by Type (2011-2021)
Figure Sales Market Share of Benign Prostatic Hyperplasia Treatment Device by Type (2011-2021)
Figure Global Benign Prostatic Hyperplasia Treatment Device Sales Growth Rate by Type (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Revenue and Market Share by Type (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Benign Prostatic Hyperplasia Treatment Device by Type (2011-2021)
Figure Global Benign Prostatic Hyperplasia Treatment Device Revenue Growth Rate by Type (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Regions (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Sales Share by Regions (2011-2021)
Figure Sales Market Share of Benign Prostatic Hyperplasia Treatment Device by Regions (2011-2021)
Figure Global Benign Prostatic Hyperplasia Treatment Device Sales Growth Rate by Regions (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Revenue and Market Share by Regions (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Benign Prostatic Hyperplasia Treatment Device by Regions (2011-2021)
Figure Global Benign Prostatic Hyperplasia Treatment Device Revenue Growth Rate by Regions (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Sales and Market Share by Application (2011-2021)
Table Global Benign Prostatic Hyperplasia Treatment Device Sales Share by Application (2011-2021)
Figure Sales Market Share of Benign Prostatic Hyperplasia Treatment Device by Application (2011-2021)
Figure Global Benign Prostatic Hyperplasia Treatment Device Sales Growth Rate by Application (2011-2021)
Figure North America Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
Figure North America Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure North America Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
Table North America Benign Prostatic Hyperplasia Treatment Device Sales by Manufacturers (2015 and 2016)
Table North America Benign Prostatic Hyperplasia Treatment Device Market Share by Manufacturers (2015 and 2016)
Table North America Benign Prostatic Hyperplasia Treatment Device Sales by Type (2015 and 2016)
Table North America Benign Prostatic Hyperplasia Treatment Device Market Share by Type (2015 and 2016)
Table North America Benign Prostatic Hyperplasia Treatment Device Sales by Applications (2015 and 2016)
Table North America Benign Prostatic Hyperplasia Treatment Device Market Share by Applications (2015 and 2016)
Figure Europe Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
Figure Europe Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure Europe Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
Table Europe Benign Prostatic Hyperplasia Treatment Device Sales by Manufacturers (2015 and 2016)
Table Europe Benign Prostatic Hyperplasia Treatment Device Market Share by Manufacturers (2015 and 2016)
Table Europe Benign Prostatic Hyperplasia Treatment Device Sales by Type (2015 and 2016)
Table Europe Benign Prostatic Hyperplasia Treatment Device Market Share by Type (2015 and 2016)
Table Europe Benign Prostatic Hyperplasia Treatment Device Sales by Applications (2015 and 2016)
Table Europe Benign Prostatic Hyperplasia Treatment Device Market Share by Applications (2015 and 2016)
Figure China Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
Figure China Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure China Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
Table China Benign Prostatic Hyperplasia Treatment Device Sales by Manufacturers (2015 and 2016)
Table China Benign Prostatic Hyperplasia Treatment Device Market Share by Manufacturers (2015 and 2016)
Table China Benign Prostatic Hyperplasia Treatment Device Sales by Type (2015 and 2016)
Table China Benign Prostatic Hyperplasia Treatment Device Market Share by Type (2015 and 2016)
Table China Benign Prostatic Hyperplasia Treatment Device Sales by Applications (2015 and 2016)
Table China Benign Prostatic Hyperplasia Treatment Device Market Share by Applications (2015 and 2016)
Figure Japan Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
Figure Japan Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure Japan Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
Table Japan Benign Prostatic Hyperplasia Treatment Device Sales by Manufacturers (2015 and 2016)
Table Japan Benign Prostatic Hyperplasia Treatment Device Market Share by Manufacturers (2015 and 2016)
Table Japan Benign Prostatic Hyperplasia Treatment Device Sales by Type (2015 and 2016)
Table Japan Benign Prostatic Hyperplasia Treatment Device Market Share by Type (2015 and 2016)
Table Japan Benign Prostatic Hyperplasia Treatment Device Sales by Applications (2015 and 2016)
Table Japan Benign Prostatic Hyperplasia Treatment Device Market Share by Applications (2015 and 2016)
Figure India Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
Figure India Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure India Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
Table India Benign Prostatic Hyperplasia Treatment Device Sales by Manufacturers (2015 and 2016)
Table India Benign Prostatic Hyperplasia Treatment Device Market Share by Manufacturers (2015 and 2016)
Table India Benign Prostatic Hyperplasia Treatment Device Sales by Type (2015 and 2016)
Table India Benign Prostatic Hyperplasia Treatment Device Market Share by Type (2015 and 2016)
Table India Benign Prostatic Hyperplasia Treatment Device Sales by Applications (2015 and 2016)
Table India Benign Prostatic Hyperplasia Treatment Device Market Share by Applications (2015 and 2016)
Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales and Growth Rate (2011-2021)
Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Device Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales Price Trend (2011-2021)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Device Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales by Type (2015 and 2016)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Device Market Share by Type (2015 and 2016)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Device Sales by Applications (2015 and 2016)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Device Market Share by Applications (2015 and 2016)
Table Bard Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Bard (2015 and 2016)
Table Dakang Medical Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Dakang Medical (2015 and 2016)
Table Visit Medical Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Visit Medical (2015 and 2016)
Table General Electric Co. Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of General Electric Co. (2015 and 2016)
Table Siemens AG Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Siemens AG (2015 and 2016)
Table Medtronic Inc. Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Medtronic Inc. (2015 and 2016)
Table Baxter International Inc. Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Baxter International Inc. (2015 and 2016)
Table Covidien plc Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Covidien plc (2015 and 2016)
Table Novartis AG Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Novartis AG (2015 and 2016)
Table Cardinal Health Inc. Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Cardinal Health Inc. (2015 and 2016)
Table Boston Scientific Corp. Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Boston Scientific Corp. (2015 and 2016)
Table Toshiba Corp. Basic Information List
Table Benign Prostatic Hyperplasia Treatment Device Sales, Revenue, Price of Toshiba Corp. (2015 and 2016)